-+ 0.00%
-+ 0.00%
-+ 0.00%

Scientific Paper Detailing Preclinical Studies of Narmafotinib in Pancreatic Cancer Now Online

Barchart·07/31/2026 07:45:00
Listen to the news

HIGHLIGHTS

Melbourne, Australia, July 31, 2026 (GLOBE NEWSWIRE) -- Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF), (“Amplia” or the “Company”), announces that a scientific manuscript detailing extensive preclinical studies of narmafotinib in pancreatic cancer has been made publicly available on the biology preprint server bioRxiv and can be accessed via this link1.

Read more at globenewswire.com

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.